Skip to main content

McGlynn Margaret G

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists McGlynn Margaret G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

FOLD Amicus Therapeutics, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 4, 2022 (view filing)May 22 daysMcGlynn Margaret GDirectorSSale−15.0K$6.99−$104.8K−28.3%38.0K after
Jan 17, 2023 (view filing)Jan 134 daysMcGlynn Margaret GDirectorSSale−15.0K$13.03−$195.4K−22.8%50.7K after
Mar 6, 2024 (view filing)Mar 4-52 daysMcGlynn Margaret GDirectorSSale−15.0K$13.35−$200.2K−20.2%59.3K after2 lots10b5-1

VRTX Vertex Pharmaceuticals Inc

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 1, 2022 (view filing)Jan 284 daysMcGlynn Margaret GDirectorSSale−5.00K$241.79−$1.21M−82.0%1.10K after4 lots
Apr 4, 2022 (view filing)Mar 314 daysMcGlynn Margaret GDirectorSSale−5.00K$262.27−$1.31M−82.0%1.10K after3 lots
Apr 12, 2022 (view filing)Apr 84 daysMcGlynn Margaret GDirectorSSale−5.00K$280.22−$1.40M−82.0%1.10K after2 lots